Taken together, these results indicate that patients who do not survive severe COVID‐19 display T cell subset imbalances at the onset of the critical phase of their disease, particularly showing decreased CD8+ frequency which is possibly due to lowered counts of CD8+ EM, CM and TEMRA. The gene discussed is CD8A; the disease is COVID-19.